Our team also focused on classifying CRC based on IHC reactions and used markers of EMT such as E-cadherin, β- catenin, vimentin, and maspin, evaluated in both tumor center and invasion front/tumor buds (Figure 2) [51,54,55]. This evidence concerns the gene CDH1 and neoplasm.